158 related articles for article (PubMed ID: 26622592)
1. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma.
Lin G; Sun XJ; Han QB; Wang Z; Xu YP; Gu JL; Wu W; Zhang GU; Hu JL; Sun WY; Mao WM
Oncol Lett; 2015 Aug; 10(2):901-906. PubMed ID: 26622592
[TBL] [Abstract][Full Text] [Related]
2. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
[TBL] [Abstract][Full Text] [Related]
3. Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer.
Guo K; Wang WP; Jiang T; Wang JZ; Chen Z; Li Y; Zhou YA; Li XF; Lu Q; Zhang LJ
J Thorac Dis; 2016 Jul; 8(7):1753-63. PubMed ID: 27499966
[TBL] [Abstract][Full Text] [Related]
4. Amplification and clinicopathological significance of HER-2 in Kazakh esophageal squamous cell carcinoma.
Muhetaer A; Niyaz M; Ainiwaer J; Liwei Z; Awut E
Mol Clin Oncol; 2020 Nov; 13(5):64. PubMed ID: 32968485
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma.
Wang X; Niu H; Fan Q; Lu P; Ma C; Liu W; Liu Y; Li W; Hu S; Ling Y; Guo L; Ying J; Huang J
Oncotarget; 2016 Apr; 7(17):24744-51. PubMed ID: 27013591
[TBL] [Abstract][Full Text] [Related]
7. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
9. Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study.
Huang J; Fan Q; Lu P; Ying J; Ma C; Liu W; Liu Y; Tan F; Sun Y
J Thorac Oncol; 2016 Jun; 11(6):910-7. PubMed ID: 26980473
[TBL] [Abstract][Full Text] [Related]
10. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification.
Itakura Y; Sasano H; Shiga C; Furukawa Y; Shiga K; Mori S; Nagura H
Cancer; 1994 Aug; 74(3):795-804. PubMed ID: 8039107
[TBL] [Abstract][Full Text] [Related]
12. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
13. Correlation of epidermal growth factor receptor mutation, immunohistochemistry, and fluorescence in situ hybridization in esophageal squamous cell carcinoma.
Sunpaweravong P; Suwiwat S; Sunpaweravong S; Puttawibul P; Mitarnun W
J Med Assoc Thai; 2009 Sep; 92(9):1136-42. PubMed ID: 19772171
[TBL] [Abstract][Full Text] [Related]
14. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus.
Hanawa M; Suzuki S; Dobashi Y; Yamane T; Kono K; Enomoto N; Ooi A
Int J Cancer; 2006 Mar; 118(5):1173-80. PubMed ID: 16161046
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy.
Gao Z; Meng X; Mu D; Sun X; Yu J
Oncol Lett; 2014 Apr; 7(4):1118-1122. PubMed ID: 24944678
[TBL] [Abstract][Full Text] [Related]
16. C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome.
Xu YP; Lin G; Sun XJ; Yan MH; Zhang G; Hu JL; Sun WY; Yu JM
J Cancer; 2016; 7(5):587-94. PubMed ID: 27053957
[TBL] [Abstract][Full Text] [Related]
17. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
[TBL] [Abstract][Full Text] [Related]
18. Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chien HT; Liao CT; Chen IH; Wang HM; Chuang WY; Wang CY; Hsieh LL
Oral Oncol; 2012 Jan; 48(1):67-72. PubMed ID: 21831696
[TBL] [Abstract][Full Text] [Related]
19. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
Huang SF; Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM
BMC Cancer; 2017 Aug; 17(1):592. PubMed ID: 28854970
[TBL] [Abstract][Full Text] [Related]
20. Expression of P-EGFR and P-Akt protein in esophageal squamous cell carcinoma and its prognosis.
Shan ZZ; Chen PN; Wang F; Wang J; Fan QX
Oncol Lett; 2017 Sep; 14(3):2859-2863. PubMed ID: 28927043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
